These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6449154)

  • 21. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat.
    Bruner LH; Hilliker KS; Roth RA
    Am J Physiol; 1983 Aug; 245(2):H300-6. PubMed ID: 6224428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
    Hislop A; Reid L
    Br J Exp Pathol; 1976 Oct; 57(5):542-54. PubMed ID: 136978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single lung transplantation in rats with chemically induced pulmonary hypertension.
    Kawaguchi AT; Mizuta T; Matsuda H; Shirakura R; Nakahara K; Tanaka H; Kawashima Y
    J Thorac Cardiovasc Surg; 1992 Mar; 103(3):483-9. PubMed ID: 1532040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D; Reid LM
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
    Lai YL; Olson JW; Gillespie MN
    J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic unloading leads to regression of pulmonary vascular disease in rats.
    O'Blenes SB; Fischer S; McIntyre B; Keshavjee S; Rabinovitch M
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):279-89. PubMed ID: 11174733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered artery mechanics and structure in monocrotaline pulmonary hypertension.
    Langleben D; Szarek JL; Coflesky JT; Jones RC; Reid LM; Evans JN
    J Appl Physiol (1985); 1988 Nov; 65(5):2326-31. PubMed ID: 3145283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
    Lalich JL; Johnson WD; Raczniak TJ; Shumaker RC
    Arch Pathol Lab Med; 1977 Feb; 101(2):69-73. PubMed ID: 138406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sequence of cellular and hemodynamic changes of chronic pulmonary hypertension induced by hypoxia and other stimuli.
    Meyrick BO; Perkett EA
    Am Rev Respir Dis; 1989 Nov; 140(5):1486-9. PubMed ID: 2683910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
    Todd L; Mullen M; Olley PM; Rabinovitch M
    Pediatr Res; 1985 Jul; 19(7):731-7. PubMed ID: 3161000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Mitani Y; Maruyama K; Sakurai M
    Circulation; 1997 Jul; 96(2):689-97. PubMed ID: 9244244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
    Hilliker KS; Roth RA
    Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.
    Pullamsetti S; Krick S; Yilmaz H; Ghofrani HA; Schudt C; Weissmann N; Fuchs B; Seeger W; Grimminger F; Schermuly RT
    Respir Res; 2005 Nov; 6(1):128. PubMed ID: 16262900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity.
    Maruyama K; Ye CL; Woo M; Venkatacharya H; Lines LD; Silver MM; Rabinovitch M
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1716-26. PubMed ID: 1836309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS; Bell TG; Lorimer D; Roth RA
    Am J Physiol; 1984 Jun; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
    Zhao L; Zhou TF; Liu HM; Li M; Dou H; Tang ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of increased pulmonary blood flow in pulmonary arterial hypertension.
    van Albada ME; Schoemaker RG; Kemna MS; Cromme-Dijkhuis AH; van Veghel R; Berger RM
    Eur Respir J; 2005 Sep; 26(3):487-93. PubMed ID: 16135733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of elastase inhibitor on pulmonary hypertension induced by monocrotaline].
    Fu LJ; Zhou AQ; Shen J; Zhao W; Li F
    Zhonghua Er Ke Za Zhi; 2004 May; 42(5):375-8. PubMed ID: 15189699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling.
    Dumitrascu R; Weissmann N; Ghofrani HA; Dony E; Beuerlein K; Schmidt H; Stasch JP; Gnoth MJ; Seeger W; Grimminger F; Schermuly RT
    Circulation; 2006 Jan; 113(2):286-95. PubMed ID: 16391154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.